Black Rock Inc. Aquestive Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,454,743 shares of AQST stock, worth $20.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,454,743

Previous 1,344,876 305.59%

Holding current value

$20.6 Million

Previous $5.73 Million 147.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.31 - $4.5 $9.49 Million - $18.5 Million	4,109,867 Added 305.59%	5,454,743 $14.2 Million
Q1 2024 May 10, 2024	BUY	$2.01 - $6.09 $1.74 Million - $5.28 Million	866,857 Added 181.34%	1,344,876 $5.73 Million
Q4 2023 Feb 13, 2024	SELL	$1.29 - $2.47 $2,514 - $4,814	-1,949 Reduced 0.41%	478,019 $965,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.24 $110,499 - $165,011	73,666 Added 18.13%	479,968 $734,000
Q2 2023 Aug 11, 2023	BUY	$1.06 - $2.49 $49,442 - $116,143	46,644 Added 12.97%	406,302 $670,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.15 $1,398 - $2,234	1,943 Added 0.54%	359,658 $410,000
Q4 2022 Feb 13, 2023	SELL	$0.77 - $1.18 $12,445 - $19,072	-16,163 Reduced 4.32%	357,715 $321,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $1.73 $1,362 - $3,740	2,162 Added 0.58%	373,878 $437,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.57 $3,072 - $12,338	-4,801 Reduced 1.28%	371,716 $237,000
Q1 2022 May 12, 2022	BUY	$2.28 - $4.26 $64,184 - $119,923	28,151 Added 8.08%	376,517 $983,000
Q4 2021 Feb 10, 2022	BUY	$3.69 - $6.37 $64,279 - $110,965	17,420 Added 5.26%	348,366 $1.35 Million
Q3 2021 Nov 09, 2021	SELL	$3.25 - $4.66 $65,221 - $93,516	-20,068 Reduced 5.72%	330,946 $1.44 Million
Q2 2021 Aug 11, 2021	BUY	$3.29 - $5.21 $1.15 Million - $1.83 Million	351,014 New	351,014 $1.39 Million

Others Institutions Holding AQST

# of Institutions

125

Shares Held

47.4M

Call Options Held

64.2K

Put Options Held

204K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $202M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account